Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel A Goldstein

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
Psychological Services|July 19, 2019
Measurement-based care implementation in a Veterans Affairs primary care-mental health integration programDaniel A Goldstein, Katherine Meyers, Maurice Endsley, et al.
JCO Oncology Practice|March 21, 2020
Mature Versus Registration Studies of Immuno-Oncology Agents: Does Value Improve With Time?Omer Ben-Aharon, Racheli Magnezi, Moshe Leshno, et al.
The Lancet. Oncology|May 5, 2023
Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancerTomer Meirson, Daniel A Goldstein, Bishal Gyawali, et al.
The Oncologist|February 14, 2018
Early Steps in the Value of Cancer Care-Many Paths Remain UnexploredDaniel A Goldstein, Carlo La Vecchia, Bernardo H L Goulart
The Oncologist|July 20, 2019
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?Omer Ben-Aharon, Racheli Magnezi, Moshe Leshno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2017
Trajectories of Injectable Cancer Drug Costs After Launch in the United StatesNoa Gordon, Salomon M Stemmer, Dan Greenberg, et al.
European Journal of Ophthalmology|July 30, 2019
Should every candidate for cataract extraction be scheduled to the preoperative clinic? The Rabin Medical Center experienceItay Elimelech Gabbay, Uri Gabbay, Daniel A Goldstein, et al.
JAMA Oncology|April 21, 2022
Enabling the Sharing of Single-Dose Vials Through Risk Mitigation to Decrease Financial ToxicityDaniel A Goldstein, R Donald Harvey, Kelvin K W Chan
JAMA Oncology|December 30, 2017
Association of Immunotherapy With Durable Survival as Defined by Value Frameworks for Cancer CareOmer Ben-Aharon, Racheli Magnezi, Moshe Leshno, et al.
The Oncologist|April 21, 2017
Kaposi Sarcoma Inflammatory Cytokine Syndrome (KICS): A Rare but Potentially Treatable ConditionMichael Karass, Emily Grossniklaus, Talal Seoud, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Psychological Services|July 19, 2019
Measurement-based care implementation in a Veterans Affairs primary care-mental health integration programDaniel A Goldstein, Katherine Meyers, Maurice Endsley, et al.
JCO Oncology Practice|March 21, 2020
Mature Versus Registration Studies of Immuno-Oncology Agents: Does Value Improve With Time?Omer Ben-Aharon, Racheli Magnezi, Moshe Leshno, et al.
The Lancet. Oncology|May 5, 2023
Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancerTomer Meirson, Daniel A Goldstein, Bishal Gyawali, et al.
The Oncologist|February 14, 2018
Early Steps in the Value of Cancer Care-Many Paths Remain UnexploredDaniel A Goldstein, Carlo La Vecchia, Bernardo H L Goulart
The Oncologist|July 20, 2019
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?Omer Ben-Aharon, Racheli Magnezi, Moshe Leshno, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2017
Trajectories of Injectable Cancer Drug Costs After Launch in the United StatesNoa Gordon, Salomon M Stemmer, Dan Greenberg, et al.
European Journal of Ophthalmology|July 30, 2019
Should every candidate for cataract extraction be scheduled to the preoperative clinic? The Rabin Medical Center experienceItay Elimelech Gabbay, Uri Gabbay, Daniel A Goldstein, et al.
JAMA Oncology|April 21, 2022
Enabling the Sharing of Single-Dose Vials Through Risk Mitigation to Decrease Financial ToxicityDaniel A Goldstein, R Donald Harvey, Kelvin K W Chan
JAMA Oncology|December 30, 2017
Association of Immunotherapy With Durable Survival as Defined by Value Frameworks for Cancer CareOmer Ben-Aharon, Racheli Magnezi, Moshe Leshno, et al.
The Oncologist|April 21, 2017
Kaposi Sarcoma Inflammatory Cytokine Syndrome (KICS): A Rare but Potentially Treatable ConditionMichael Karass, Emily Grossniklaus, Talal Seoud, et al.
Pageof 14